ProMIS Neurosciences Inc. (PMN)

Latest Insider Confidence Score

2026Q1

62.6
Bullish

Company insider confidence (by quarter)

2022Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Jeremy M. Sclar 2012 Irrevocable Family Trust — 6,849,992 Sep 30, 2025
Shaf QIC LLC — 5,184,760 Aug 14, 2025
Shafmaster Jonathan — 5,184,760 Aug 14, 2025
Gordon Michael S 10% Owner 2,974,129 Jul 29, 2025
Title 19 Promis — 2,974,129 Jul 29, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 5, 2026 Mar 6, 2026 Williams Eugene Director Buy 91.3 +2,000 19.24% ✗ $48.8K
Mar 2, 2026 Mar 4, 2026 Williams Eugene Director Buy 95.0 +4,000 62.53% ✗ $92.4K
Feb 25, 2026 ABG V-SIV IX Ltd 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 19, 2026 Feb 23, 2026 Kaplan Johanne Chief Development Officer Buy 91.3 +1,629 70.46% ✗ $25K
Feb 3, 2026 Feb 5, 2026 Cashman Neil Chief Scientific Officer Neutral 90.0 +4,122 79.33% ✗ -
Feb 3, 2026 Feb 5, 2026 Kaplan Johanne Chief Development Officer Neutral 90.0 +2,060 817.46% ✗ -
Feb 3, 2026 Feb 5, 2026 Warma Neil K CEO Neutral 90.0 +6,183 100.00% ✗ -
Feb 3, 2026 Feb 5, 2026 Milbury Max A. Other Neutral 90.0 +6,595 363.56% ✗ -
Feb 3, 2026 Feb 5, 2026 Kirwin Patrick D. Director Neutral 90.0 +3,050 75.44% ✗ -
Feb 3, 2026 Feb 5, 2026 ABG Management Ltd. 10% Owner Buy 100.0 +700,741 289.15% ✗ $8.5M
Oct 22, 2025 Oct 24, 2025 ABG Management Ltd. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 24, 2025 Alex Slanix Paul Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2025 Oct 6, 2025 Milbury Max A. Other Buy 91.3 +30,392 202.65% ✗ $14.9K
Jul 25, 2025 Sep 30, 2025 Jeremy M. Sclar 2012 Irrevocable Family Trust 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 30, 2025 Jeremy M. Sclar 2012 Irrevocable Family Trust 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 22, 2025 Sep 24, 2025 Warma Neil K CEO Neutral 52.5 - 0.00% ✗ -
Sep 22, 2025 Sep 24, 2025 Milbury Max A. Other Neutral 52.5 - 0.00% ✗ -
Sep 22, 2025 Sep 24, 2025 Cashman Neil Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Sep 22, 2025 Sep 24, 2025 Kaplan Johanne Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Sep 22, 2025 Sep 24, 2025 ALTSTIEL LARRY DOUGLAS Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 25, 2025 Sep 8, 2025 Sclar Jeremy M. 10% Owner Neutral 52.5 - 0.00% ✗ -
Aug 14, 2025 Shaf QIC LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 25, 2025 Aug 14, 2025 Title 19 Promis Other Neutral 52.5 - 0.00% ✗ -
Jul 25, 2025 Aug 14, 2025 GORDON MICHAEL S Other Neutral 52.5 - 0.00% ✗ -
Mar 13, 2025 Aug 14, 2025 GORDON MICHAEL S Other Neutral 27.5 -48,333 -1.95% ✗ -
Aug 4, 2025 ABG Management Ltd. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 25, 2025 Jul 29, 2025 GORDON MICHAEL S 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 25, 2025 Jul 29, 2025 Title 19 Promis 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 2, 2025 GORDON MICHAEL S 10% Owner Neutral 27.5 -93,223 -4.20% ✗ -
Jun 12, 2025 Jun 16, 2025 Mandel-Brehm Josh Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 16, 2025 Kirwin Patrick D. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 16, 2025 Shafmaster Madge K. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 16, 2025 WYMAN WILLIAM W Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 16, 2025 Williams Eugene Director Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 12, 2025 Cashman Neil Chief Scientific Officer Buy 91.3 +15,000 13.05% ✗ $14.6K
Nov 18, 2024 Nov 20, 2024 Milbury Max A. Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Nov 18, 2024 Nov 20, 2024 Kaplan Johanne Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Nov 18, 2024 Nov 20, 2024 Cashman Neil Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Nov 18, 2024 Nov 20, 2024 ALTSTIEL LARRY DOUGLAS Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 8, 2024 Oct 10, 2024 Warma Neil K CEO Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 WYMAN WILLIAM W Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 Williams Eugene Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 Shafmaster Madge K. Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 Mandel-Brehm Josh Director Neutral 52.5 - 0.00% ✗ -
Oct 3, 2024 Oct 7, 2024 Kirwin Patrick D. Director Neutral 52.5 - 0.00% ✗ -
Sep 20, 2024 Sep 24, 2024 Shafmaster Madge K. Director Buy 97.5 +200,000 2400.10% ✗ $255.8K
Sep 16, 2024 Sep 18, 2024 GORDON MICHAEL S 10% Owner Buy 87.5 +93,223 4.39% ✗ $116.9K
Aug 14, 2024 Aug 16, 2024 Kirwin Patrick D. Director Buy 91.3 +10,000 11.22% ✗ $12.5K
Jul 31, 2024 Aug 2, 2024 Title 19 Promis 10% Owner Neutral 90.0 +465,116 41.88% ✗ -
Jul 31, 2024 Aug 2, 2024 GORDON MICHAEL S 10% Owner Neutral 90.0 +465,116 40.14% ✗ -
Jul 31, 2024 Aug 2, 2024 Sclar Jeremy M. 10% Owner Neutral 90.0 +697,674 83.58% ✗ -
Jan 2, 2024 Jan 5, 2024 Warma Neil K CEO Neutral 52.5 - 0.00% ✗ -
Dec 4, 2023 Jan 2, 2024 Sclar Jeremy M. 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 27, 2023 Title 19 Promis 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 27, 2023 GORDON MICHAEL S 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 Malenfant Gavin T. COO Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 Kaplan Johanne Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 ALTSTIEL LARRY DOUGLAS Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 Milbury Max A. Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 Cashman Neil Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 26, 2023 Oct 30, 2023 Geffken Daniel E. CFO Neutral 52.5 - 0.00% ✗ -
Sep 5, 2023 Sclar Jeremy M. 10% Owner Neutral 52.5 - 0.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Farfel Gail M CEO Neutral 90.0 +53,192 2659.60% ✗ -
Aug 23, 2023 Aug 25, 2023 Kirwin Patrick D. Director Neutral 90.0 +11,000 14.09% ✗ -
Aug 23, 2023 Aug 25, 2023 Malenfant Gavin T. COO Neutral 90.0 +2,660 100.00% ✗ -
Aug 23, 2023 Aug 25, 2023 Cashman Neil Chief Scientific Officer Neutral 90.0 +10,643 10.21% ✗ -
Aug 23, 2023 Aug 25, 2023 Milbury Max A. Principal Accounting Officer Neutral 90.0 +13,297 782.18% ✗ -
Mar 16, 2023 Kaplan Johanne Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Dec 16, 2022 Dec 19, 2022 Williams Eugene Director Buy 77.5 +2,000 1.27% ✗ $9.3K
Dec 14, 2022 Dec 16, 2022 Farfel Gail M CEO Buy 90.0 +1,000 100.00% ✗ $4.9K
Dec 13, 2022 Dec 15, 2022 Kirwin Patrick D. Director Buy 83.8 +3,000 3.99% ✗ $13.9K
Dec 12, 2022 Dec 13, 2022 Williams Eugene Director Buy 67.5 +1,000 0.64% ✗ $5.1K
Dec 9, 2022 Dec 13, 2022 Kirwin Patrick D. Director Buy 77.5 +1,000 1.35% ✗ $5K
Dec 7, 2022 Dec 8, 2022 Williams Eugene Director Buy 67.5 +1,000 0.64% ✗ $5.5K
Dec 6, 2022 Dec 8, 2022 Farfel Gail M CEO Buy 90.0 +1,000 100.00% ✗ $5.7K
Dec 2, 2022 Dec 6, 2022 Williams Eugene Director Buy 67.5 +1,000 0.65% ✗ $6K
Sep 19, 2022 Sep 20, 2022 Farfel Gail M CEO Neutral 52.5 - 0.00% ✗ -
Sep 20, 2022 Farfel Gail M CEO Neutral 52.5 - 0.00% ✗ -
Aug 17, 2022 Aug 18, 2022 Kirwin Patrick D. Director Buy 86.3 +4,000 5.85% ✗ $23.7K
Jul 11, 2022 Jul 12, 2022 Williams Eugene CEO Buy 67.5 +1,000 0.65% ✗ $9.8K
Jul 7, 2022 ALTSTIEL LARRY DOUGLAS Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Williams Eugene CEO Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Geffken Daniel E. CFO Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Gregory Richard J. Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Malenfant Gavin T. COO Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Mandel-Brehm Josh Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Milbury Max A. Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Cashman Neil Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Kirwin Patrick D. Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Shafmaster Madge K. Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 Warma Neil K Director Neutral 52.5 - 0.00% ✗ -
Jul 7, 2022 WYMAN WILLIAM W Director Neutral 52.5 - 0.00% ✗ -